647 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

YMTX

Yumanity Therapeutics
US$13.23-8.3%-41.3%US$143.6mn/aPS29.7xn/an/a

ALPN

Alpine Immune Sciences
US$64.970.03%518.2%US$4.5bUS$62.00PS78.9xE-9.9%n/a

TALS

Talaris Therapeutics
US$27.20-4.9%91.5%US$553.2mUS$200.00PB3.7xn/an/a

EQRX

EQRx
US$2.34-5.3%-36.2%US$1.1bn/aPB1xS123.3%n/a

NGM

NGM Biopharmaceuticals
US$1.54-3.1%-59.8%US$128.5mUS$1.55PS29.1xE14.7%n/a

KDNY

Chinook Therapeutics
US$40.390.3%95.7%US$2.9bUS$40.09PS495.8xE22.6%n/a

SGMT

Sagimet Biosciences
US$5.378.0%-32.6%US$172.9mUS$29.14PB1xE-18.5%n/a

SLN

Silence Therapeutics
US$6.34-14.2%-64.2%US$299.3mUS$53.70PS15xE6.8%n/a

LCTX

Lineage Cell Therapeutics
US$0.53-9.8%-51.6%US$117.3mUS$4.50PS13.5xE43.1%n/a

BRNS

Barinthus Biotherapeutics
US$1.14-3.4%-66.1%US$45.9mUS$7.25PS3.1xE-1.8%n/a

KOD

Kodiak Sciences
US$9.200.9%178.8%US$483.0mUS$6.67PB2.6xE1.8%n/a

KYTX

Kyverna Therapeutics
US$3.80-7.3%n/aUS$164.1mUS$27.33PB0.5xE-21.7%n/a

TRML

Tourmaline Bio
US$20.00-6.7%-34.4%US$512.9mUS$57.29PB1.6xE-0.2%n/a

TRVI

Trevi Therapeutics
US$4.03-12.2%183.8%US$309.8mUS$9.94PB5.3xE37.8%n/a

TCBP

TC Biopharm (Holdings)
US$0.41-3.1%-98.0%US$3.3mUS$2.40PB1.3xE-10.1%n/a

NTRB

Nutriband
US$4.27-15.8%47.2%US$47.4mn/aPS23.5xn/an/a

RNXT

RenovoRx
US$1.32-4.3%20.0%US$31.7mUS$5.50PB4.5xE63.5%n/a

PASG

Passage Bio
US$0.66-20.5%-39.0%US$40.7mUS$8.00PB0.6xE47.3%n/a

PMCB

PharmaCyte Biotech
US$1.661.2%-26.2%US$11.6mn/aPE1.2xn/an/a

QGEN

Qiagen
US$45.260.6%-2.3%US$10.1bUS$51.14PE108.2xE34.4%2.8%

ALDX

Aldeyra Therapeutics
US$5.11-6.2%59.2%US$304.3mUS$10.00PB3.6xE59.9%n/a

PROK

ProKidney
US$1.66-10.8%3.1%US$484.2mUS$4.67PE-4.7xE1.0%n/a

VYGR

Voyager Therapeutics
US$5.73-5.1%-27.1%US$313.0mUS$17.10PE12.1xE-24.2%n/a

MURA

Mural Oncology
US$3.656.7%-23.0%US$62.3mUS$16.33PB0.4xE26.7%n/a
Page 1 of 27